<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00150000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P21589</UniProt_ID>
  <Seq_Length>574</Seq_Length>
  <Molecule_Weight>63368</Molecule_Weight>
  <KEGG_ID>hsa:4907</KEGG_ID>
  <Orthology_ID>K01081</Orthology_ID>
  <Function_Summary>Hydrolyzes extracellular nucleotides into membrane permeable nucleosides. Exhibits AMP-, NAD-, and NMN-nucleosidase activities.</Function_Summary>
  <Catalytic_Mechanism>A 5'-ribonucleotide + H(2)O = a ribonucleoside + phosphate.</Catalytic_Mechanism>
  <Pfam_ID>PF02872:5_nucleotid_C@@PF00149:Metallophos</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>3</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>5'-NT</Alias>
      <Alias>Ecto-5'-nucleotidase</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the hydrolysis of various bonds, e.g. C-O, C-N, C-C, phosphoric anhydride bonds, etc. Hydrolase is the systematic name for any enzyme of EC class 3.</Detail>
      <Keyword>Hydrolase activity</Keyword>
      <Ontology_ID>GO:0016787</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any metal ion.</Detail>
      <Keyword>Metal ion binding</Keyword>
      <Ontology_ID>GO:0046872</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: a 5'-ribonucleotide + H2O = a ribonucleoside + phosphate.</Detail>
      <Keyword>5'-nucleotidase activity</Keyword>
      <Ontology_ID>GO:0008253</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>376</Position>
      <Original>Thr</Original>
      <Variation>Ala</Variation>
    </Muntion>
    <Muntion>
      <Position>358</Position>
      <Original>Cys</Original>
      <Variation>Tyr</Variation>
    </Muntion>
    <Muntion>
      <Position>379</Position>
      <Original>Met</Original>
      <Variation>Thr</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving purine bases, one of the two classes of nitrogen-containing ring compounds found in DNA and RNA, which include adenine and guanine.</Detail>
      <Keyword>Purine base metabolic process</Keyword>
      <Ontology_ID>GO:0006144</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of one of a family of organic molecules consisting of a pyrimidine base covalently bonded to a sugar ribose (a ribonucleoside) or deoxyribose (a deoxyribonucleoside).</Detail>
      <Keyword>Pyrimidine nucleoside catabolic process</Keyword>
      <Ontology_ID>GO:0046135</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the formation of adenosine, adenine riboside, a ribonucleoside found widely distributed in cells of every type as the free nucleoside and in combination in nucleic acids and various nucleoside coenzymes.</Detail>
      <Keyword>Adenosine biosynthetic process</Keyword>
      <Ontology_ID>GO:0046086</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways involving pyrimidine bases, 1,3-diazine, organic nitrogenous bases.</Detail>
      <Keyword>Pyrimidine base metabolic process</Keyword>
      <Ontology_ID>GO:0006206</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of the inflammatory response.</Detail>
      <Keyword>Negative regulation of inflammatory response</Keyword>
      <Ontology_ID>GO:0050728</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any cellular metabolic process involving deoxyribonucleic acid. This is one of the two main types of nucleic acid, consisting of a long, unbranched macromolecule formed from one, or more commonly, two, strands of linked deoxyribonucleotides.</Detail>
      <Keyword>DNA metabolic process</Keyword>
      <Ontology_ID>GO:0006259</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of AMP, adenosine monophosphate.</Detail>
      <Keyword>AMP catabolic process</Keyword>
      <Ontology_ID>GO:0006196</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The chemical reactions and pathways resulting in the breakdown of a purine nucleotide, a compound consisting of nucleoside (a purine base linked to a deoxyribose or ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.</Detail>
      <Keyword>Purine nucleotide catabolic process</Keyword>
      <Ontology_ID>GO:0006195</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <Molecule_Seq>
    <Protein_Seq>MCPRAARAPATLLLALGAVLWPAAGAWELTILHTNDVHSRLEQTSEDSSKCVNASRCMGGVARLFTKVQQIRRAEPNVLLLDAGDQYQGTIWFTVYKGAEVAHFMNALRYDAMALGNHEFDNGVEGLIEPLLKEAKFPILSANIKAKGPLASQISGLYLPYKVLPVGDEVVGIVGYTSKETPFLSNPGTNLVFEDEITALQPEVDKLKTLNVNKIIALGHSGFEMDKLIAQKVRGVDVVVGGHSNTFLYTGNPPSKEVPAGKYPFIVTSDDGRKVPVVQAYAFGKYLGYLKIEFDERGNVISSHGNPILLNSSIPEDPSIKADINKWRIKLDNYSTQELGKTIVYLDGSSQSCRFRECNMGNLICDAMINNNLRHTDEMFWNHVSMCILNGGGIRSPIDERNNGTITWENLAAVLPFGGTFDLVQLKGSTLKKAFEHSVHRYGQSTGEFLQVGGIHVVYDLSRKPGDRVVKLDVLCTKCRVPSYDPLKMDEVYKVILPNFLANGGDGFQMIKDELLRHDSGDQDINVVSTYISKMKVIYPAVEGRIKFSTGSHCHGSFSLIFLSLWAVIFVLYQ</Protein_Seq>
    <DNA_Seq>ACTCCTCCTCTCTGCCCCTCAGCTCGCTCATCTTTCTTCCCGCCCCCTCTCTTTTCCTTCTTTGGTTCTTTGAAGTGATGAGCTAGCGCAACCACAAACCATACATTCCTTTTGTAGAAAAACCCGTGCCTCGAATGAGGCGAGACTCAGAGAGGACCCAGGCGCGGGGCGGACCCCTCCAATTCCTTCCTCGCGCCCCCGAAAGAGCGGCGCACCAGCAGCCGAACTGCCGGCGCCCAGGCTCCCTGGTCCGGCCGGGATGCGGCCGGTACCCGCTCCCCGCCGGGAACAACCTCTCCACTCTTCCTGCAGGGAGCTGGTGCCAGCCGACAGCCGCGCCAGGGCCGCTCCGGGTACCAGGGTCGGATCGGGTGACGTCGCGAACTTGCGCCTGGCCGCCAAGCCGGCCTCCAGGCTGAAGAAGGACCCGCCCCGGCCTTGACCCGGGCCCCGCCCCTCCAGCCGGGGCACCGAGCCCCGGCCCTAGCTGCTCGCCCCTACTCGCCGGCACTCGCCCGGCTCGCCCGCTTTCGCACCCAGTTCACGCGCCACAGCTATGTGTCCCCGAGCCGCGCGGGCGCCCGCGACGCTACTCCTCGCCCTGGGCGCGGTGCTGTGGCCTGCGGCTGGCGCCTGGGAGCTTACGATTTTGCACACCAACGACGTGCACAGCCGGCTGGAGCAGACCAGCGAGGACTCCAGCAAGTGCGTCAACGCCAGCCGCTGCATGGGTGGCGTGGCTCGGCTCTTCACCAAGGTTCAGCAGATCCGCCGCGCCGAACCCAACGTGCTGCTGCTGGACGCCGGCGACCAGTACCAGGGCACTATCTGGTTCACCGTGTACAAGGGCGCCGAGGTGGCGCACTTCATGAACGCCCTGCGCTACGATGCCATGGCACTGGGAAATCATGAATTTGATAATGGTGTGGAAGGACTGATCGAGCCACTCCTCAAAGAGGCCAAATTTCCAATTCTGAGTGCAAACATTAAAGCAAAGGGGCCACTAGCATCTCAAATATCAGGACTTTATTTGCCATATAAAGTTCTTCCTGTTGGTGATGAAGTTGTGGGAATCGTTGGATACACTTCCAAAGAAACCCCTTTTCTCTCAAATCCAGGGACAAATTTAGTGTTTGAAGATGAAATCACTGCATTACAACCTGAAGTAGATAAGTTAAAAACTCTAAATGTGAACAAAATTATTGCACTGGGACATTCGGGTTTTGAAATGGATAAACTCATCGCTCAGAAAGTGAGGGGTGTGGACGTCGTGGTGGGAGGACACTCCAACACATTTCTTTACACAGGCAATCCACCTTCCAAAGAGGTGCCTGCTGGGAAGTACCCATTCATAGTCACTTCTGATGATGGGCGGAAGGTTCCTGTAGTCCAGGCCTATGCTTTTGGCAAATACCTAGGCTATCTGAAGATCGAGTTTGATGAAAGAGGAAACGTCATCTCTTCCCATGGAAATCCCATTCTTCTAAACAGCAGCATTCCTGAAGATCCAAGCATAAAAGCAGACATTAACAAATGGAGGATAAAATTGGATAATTATTCTACCCAGGAATTAGGGAAAACAATTGTCTATCTGGATGGCTCCTCTCAATCATGCCGCTTTAGAGAATGCAACATGGGCAACCTGATTTGTGATGCAATGATTAACAACAACCTGAGACACACGGATGAAATGTTCTGGAACCACGTATCCATGTGCATTTTAAATGGAGGTGGTATCCGGTCGCCCATTGATGAACGCAACAATGGAATCCATGTGGTGTATGATCTTTCCCGAAAACCTGGAGACAGAGTAGTCAAATTAGATGTTCTTTGCACCAAGTGTCGAGTGCCCAGTTATGACCCTCTCAAAATGGACGAGGTATATAAGGTGATCCTCCCAAACTTCCTGGCCAATGGTGGAGATGGGTTCCAGATGATAAAAGATGAATTATTAAGACATGACTCTGGTGACCAAGATATCAACGTGGTTTCTACATATATCTCCAAAATGAAAGTAATTTATCCAGCAGTTGAAGGTCGGATCAAGTTTTCCACAGGAAGTCACTGCCATGGAAGCTTTTCTTTAATATTTCTTTCACTTTGGGCAGTGATCTTTGTTTTATACCAATAGCCAAAAATTCTCCTTGCCTTTAATGTGTGAAACTGCATTTTTTCAAGTGAGATTCAAATCTGCCTTTTAGGACCTGGCTTTGTGACAGCAAAAACCATCTTTACAGGCTCCTAGAAGCTGAAGGTTAGAGCATTATAAAATGAAGAGACAGACATGATTACTCAGGGTCAGCAACCTAGTGAGTTAGAAAAAAAATTAACATAGGGCCCTATAAGGAGAAAGCCAACTATGTTAAGTTTACGTGTCCAAATTTTAATGAAATTTTACTAACAATTTTAAACCATATTTTTCTTCTTCATATCCATTTCTAATCCATCAAACAGCTTATGTTTACATAAAATTTTATCATTCACAAGGAAGTTTTAAGCACACTGTCTCATTTGATATCCACAACTTATTTTTGGTAGGAAAGAGAGATGTTTTTCCCACCTGTCAGATGAAAAAACTGAAGCTCAAAAAGGGTTGACTTGACCATACAGCTAATGCTGACAGATCCAAGACCTAGACCTAGGTCTTTTGAACTCAAGTCCAGCATTCTCAACTATATCAAGTTACTGTTCAGAATACTTAATATCTCCTCTCTTCATAATTATCAATAGCCCCAAGCTCATGGATGACAAATCTCTGCTTTATTTCTTGTCTCTATTTTTTCACTTTATAGCTCCTGTTATAATAGCAAGTTTAATGGTATAAACACAGGATACCATCCTCTCTTGCAACACCCATGTGCCTTTGATGAGTCAGGTAGCAAGCTGTAGTAGATAATGAGAAAGGCCAGAGGCTGCAAAAGACAGTCAAAGGACACGAGAGAAAGGAAGGGGAAGAACAGGACTCCAGGACTGTTTTATATTATAGAAAAGCAAGAGCTAAAGAGCATTTACACATGTTAAACAGATACTTGTTAAGCATAGTGCCTGACACACGGCATTAGCTGTTATTTTATGAGATTCCATCAGCTCTGCCTCTGTCCTCTTTCTTCTAACATGAAGGTATCATGAGAAGAGAACCTTCTAACATAAGCTGTAATTCTAAACCTGCACTTGTCCCTCTCCAGCAAGAGGCTAGCACTGAATTCATTCTACTCATACTACACACCCAGTTATGGAATGTCCAGAGTTCTCGAAGAAAATAAATGACTTTAGGAAGAGGTATACATTTTTTAAGTCGCTCTGCCTCCAAATCTGAACAGTCACTGTAAATCATTCTTAAGCCCAGATATGAGAACTTCTGCTGGAAAGTGGGACCCTCTGAGTGGGTGGTCAGAAAATACCCATGCTGATGAAATGACCTATGCCCAAAGAACAAATACTTAACGTGGGAGTGGAACCACATGAGCCTGCTCAGCTCTGCATAAGTAATTCAAGAAATGGGAGGCTTCACCTTAAAAACAGTGTGCAAATGGCAGCTAGAGGTTTTGATAGGAAGTATGTTTGTTTCTTAGTGTTTACAAATATTAAGTACTCTTGATACAAAATATACTTTTAAACTTCATAACCTTTTTATAAAAGTTGTTGCAGCAAAATAATAGCCTCGGTTCTATGCATATATGGATTAGCTATAAAAAATGTCAATAAGATTGTACAAGGAAAATTAGAGAAAGTCACATTTAGGGTTTATTTTTTACACTTGGCCAGTAAAATAGGGTAAATCCTATTAGAATTTTTTAAAGAACTTTTTTTAAGTTTCCTAAATCTGTGTGTGTATTGTGAAGTGGTATAAGAAATGACTTTGAACCACTTTGCAATTGTAGATTCCCAACAATAAAATTGAAGATAAGCTCTTTGGTCAAAAAAAAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Extracellular vesicular exosome</CellLocal>
      <Ontology_ID>GO:0070062</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Anchored to membrane</CellLocal>
      <Ontology_ID>GO:0031225</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Plasma membrane</CellLocal>
      <Ontology_ID>GO:0005886</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane</CellLocal>
      <Ontology_ID>GO:0016020</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cell membrane</CellLocal>
      <Ontology_ID>SwissProt</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>NT5E</Gene_Name>
    <Gene_Alias>NT5; NTE</Gene_Alias>
    <Gene_ID>4907</Gene_ID>
    <Genbank_ACCN>NM_001204813</Genbank_ACCN>
    <Protein_ACCN>NP_001191742</Protein_ACCN>
    <HGNC_ID>8021</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/4907</Gene_URL>
    <UCSC_ID>uc010kbr.3</UCSC_ID>
    <EMBL_ID>ENSG00000135318</EMBL_ID>
  </Gene>
  <Disease_List>
    <Disease>
      <Disease_Name>Intestinal Tuberculosis</Disease_Name>
      <Disease_Detail>Intestinal Tuberculosis</Disease_Detail>
      <Disease_DB>INT046</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/intestinal_tuberculosis?search=NT5E#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Calcification of Joints and Arteries</Disease_Name>
      <Disease_Detail>Calcification of Joints and Arteries</Disease_Detail>
      <Disease_DB>CLC017</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/calcification_of_joints_and_arteries?search=NT5E#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with adenosine</PDB_Title>
      <PDB_ID>4H2G</PDB_ID>
      <Resolution>1.55</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4H2G</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Human Ecto-5'-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling.</PubMed_Title>
      <Author>Knapp, K., et al.</Author>
      <Journal>Structure(2012)20:2161-2173</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23142347?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with Baicalin</PDB_Title>
      <PDB_ID>4H2B</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4H2B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Human Ecto-5'-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling.</PubMed_Title>
      <Author>Knapp, K., et al.</Author>
      <Journal>Structure(2012)20:2161-2173</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23142347?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of a Truncated Soluble form of Human CD73 with Ecto-5'-Nucleotidase activity</PDB_Title>
      <PDB_ID>4H1S</PDB_ID>
      <Resolution>2.2</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4H1S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal structure of a soluble form of human CD73 with ecto-5'-nucleotidase activity.</PubMed_Title>
      <Author>Heuts, D.P., et al.</Author>
      <Journal>Chembiochem(2012)13:2384-2391</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/22997138?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human ecto-5'-nucleotidase (CD73): crystal form III (closed) in complex with AMPCP</PDB_Title>
      <PDB_ID>4H2I</PDB_ID>
      <Resolution>2.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4H2I</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Human Ecto-5'-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling.</PubMed_Title>
      <Author>Knapp, K., et al.</Author>
      <Journal>Structure(2012)20:2161-2173</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23142347?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human ecto-5'-nucleotidase (CD73): crystal form I (open) in complex with adenosine</PDB_Title>
      <PDB_ID>4H2F</PDB_ID>
      <Resolution>1.85</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4H2F</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Human Ecto-5'-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling.</PubMed_Title>
      <Author>Knapp, K., et al.</Author>
      <Journal>Structure(2012)20:2161-2173</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23142347?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Human ecto-5'-nucleotidase (CD73): crystal form II (open) in complex with PSB11552</PDB_Title>
      <PDB_ID>4H1Y</PDB_ID>
      <Resolution>1.58</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=4H1Y</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Crystal Structure of the Human Ecto-5'-Nucleotidase (CD73): Insights into the Regulation of Purinergic Signaling.</PubMed_Title>
      <Author>Knapp, K., et al.</Author>
      <Journal>Structure(2012)20:2161-2173</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/23142347?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>3.1.3.5</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC3/1/3/5.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Modulator_List>
    <Modulator>
      <ASD_ID>ASD00150001</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00150002</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
    <Modulator>
      <ASD_ID>ASD00150003</ASD_ID>
      <Modulator_Feature>Inhibitor</Modulator_Feature>
    </Modulator>
  </Modulator_List>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>